je.st
news
Tag: merck
Health Care SPDR Consolidating Gains as J&J, Merck Show Negative Trends
2014-12-30 13:21:46| Food - Topix.net
This exchange-traded fund has a year-to-date gain of 25% despite peaking with an all-time intraday high at $71.42 on Dec.8. The health care sector has thus outperformed the Dow 30 and S&P 500 and their gains of 8.9% and 13%, respectively. The Dow 30 and S&P 500 set all-time intraday highs on Friday at 18103 and 2092.7, respectively.
Tags: show
health
care
health care
Sale of Sigma-Aldrich to Merck gets antitrust approval
2014-12-24 11:00:45| Chemicals - Topix.net
Merck KGaA's pending $17 billion purchase of St. Louis-based Sigma-Aldrich Corp. has cleared U.S. antitrust hurdles. The acquisition's waiting period under the Hart-Scott-Rodino Antitrust Improvements Act expired Monday, Sigma-Aldrich officials said in a release .
Tags: sale
approval
merck
antitrust
Merck begins offer for Cubist shares in $8.4 billion deal
2014-12-20 11:42:26| Biotech - Topix.net
The drugmaker Merck is launching its previously-disclosed $8.4 billion offer to buy Cubist Pharmaceuticals shares in a deal that aims to strengthen its ability to treat serious infections, an issue drawing growing concern globally. Merck said earlier this month that it will pay $102 in cash for each share of Cubist, which represented a 37 percent premium to the stock's closing price before the deal was announced.
Tags: offer
deal
begins
shares
Merck Begins Tender Offer to Acquire Cubist
2014-12-19 14:00:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, is commencing today, through a subsidiary, a cash tender to purchase all outstanding shares of common stock of Cubist Pharmaceuticals, Inc. (NASDAQ:CBST). On Dec. 8, 2014, Merck announced its intent to acquire Cubist. Language: English Contact: MerckMedia:Lainie Keller, 908-236-5036Steve Cragle, 908-740-1801orInvestors:Joe Romanelli, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE Ticker: CBST Exchange: NASDAQ read more
Tags: offer
begins
acquire
tender
Merck buys Swiss biotech with promising cancer drug
2014-12-18 19:05:10| Biotech - Topix.net
Drugmaker Merck says it's bought a Swiss biotech company developing cancer drugs as part of its strategy to be a top player in cancer, one of the hottest pharmaceutical research areas. Merck & Co., based in Kenilworth, New Jersey, will pay up to $110 million upfront to OncoEthix.
Tags: drug
cancer
swiss
promising
Sites : [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] next »